Kasyanov ED, Yakovleva YV, Shchepkin ES, Mazo GE. Ignoring atypical symptoms of depression in common scales. World J Psychiatry 2025; 15(11): 107832 [DOI: 10.5498/wjp.v15.i11.107832]
Corresponding Author of This Article
Evgeny D Kasyanov, MD, PhD, Department of Social Neuropsychiatry, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Bekhtereva St., 3, 192019, Saint Petersburg 19000, Sankt-Peterburg, Russia. i@kasyan.ru
Research Domain of This Article
Psychiatry
Article-Type of This Article
Systematic Reviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Nov 19, 2025 (publication date) through Nov 24, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Kasyanov ED, Yakovleva YV, Shchepkin ES, Mazo GE. Ignoring atypical symptoms of depression in common scales. World J Psychiatry 2025; 15(11): 107832 [DOI: 10.5498/wjp.v15.i11.107832]
World J Psychiatry. Nov 19, 2025; 15(11): 107832 Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.107832
Ignoring atypical symptoms of depression in common scales
Evgeny D Kasyanov, Yana V Yakovleva, Egor S Shchepkin, Galina E Mazo
Evgeny D Kasyanov, Yana V Yakovleva, Egor S Shchepkin, Department of Social Neuropsychiatry, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint Petersburg 190000, Sankt-Peterburg, Russia
Galina E Mazo, Deputy Director for Innovative Scientific and Innovative Development, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint Petersburg 190000, Sankt-Peterburg, Russia
Author contributions: Kasyanov ED designed the review framework and identified the research focus and analyzed the data and drafted the manuscript; Yakovleva YV and Shchepkin ES conducted the literature search and selected relevant studies; Kasyanov ED and Mazo GE conducted a data synthesis; Mazo GE provided critical revisions and final approval of the manuscript; and all the authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Evgeny D Kasyanov, MD, PhD, Department of Social Neuropsychiatry, V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Bekhtereva St., 3, 192019, Saint Petersburg 19000, Sankt-Peterburg, Russia. i@kasyan.ru
Received: April 1, 2025 Revised: May 28, 2025 Accepted: September 10, 2025 Published online: November 19, 2025 Processing time: 220 Days and 8.1 Hours
Abstract
BACKGROUND
Atypical depression is an important indicator of a high risk of bipolar disorder and a genetic predisposition to immunometabolic traits.
AIM
To analyze common depression assessment scales for their inclusion of items related to atypical symptoms such as mood reactivity, hypersomnia, increased appetite (or weight gain), leaden paralysis, and interpersonal sensitivity.
METHODS
A search for English-language articles was conducted without time restrictions in the MEDLINE and Russian Science Citation Index databases using the following keywords: “depression” OR “bipolar depression” AND “scales” OR “questionnaires”. The analytical method used in this review involved a descriptive analysis of the included studies.
RESULTS
After reviewing studies on the validation of depression assessment scales, we found that only a small number include items addressing both increases and decreases in appetite or weight, as well as variations in sleep duration. Moreover, only a few studies have evaluated mood reactivity, leaden paralysis, and interpersonal sensitivity. The most well-developed scale that considers all aspects of atypical and non-atypical depressions is the Inventory of Depressive Symptomatology.
CONCLUSION
Ignoring atypical symptoms in common scales can lead to underestimation of depression severity and inaccuracies in evaluating therapy effectiveness in clinical trials, as well as hinder fundamental research aimed at finding biomarkers.
Core Tip: Common depression rating scales do not fully address atypical symptoms (e.g., mood reactivity, hypersomnia, hyperphagia, leaden paralysis, and interpersonal sensitivity), potentially underestimating atypical depression severity. Only three scales cover all five atypical features, with the Inventory of Depressive Symptomatology offering the most comprehensive assessment. Incorporating atypical symptoms is crucial for accurate severity evaluation and advancing both clinical and basic research on depression.
